Histogenics Corporation (NASDAQ: HSGX) today announced the pricing of an underwritten registered direct offering of 2,340,430 shares of its common ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE